This 135-page “Artificial Intelligence for Drug Discovery Landscape Overview Q3 2022” report represents the eleventh issue of market analytics focused on the Artificial Intelligence (AI) application in the pharmaceutical research industry.
The primary goal of this series of reports is to give a complete picture of the industry environment in terms of AI usage in drug discovery, clinical research, and other elements of pharmaceutical research and development. This overview highlights recent trends and insights in the form of helpful mind maps and infographics and gauges the performance of prominent players who shape the industry’s space and relationships. It can help the reader comprehend what is going on in the sector and potentially predict what will happen next.
Since the last edition, data has been significantly updated to reflect the fast-paced market dynamics and an overall increase in pharmaceutical AI investment and business development activities. The listings of AI-biotech businesses, biotech investors, and pharmaceutical organizations have been expanded to reflect the pharmaceutical industry’s rising interest in sophisticated data analytics technology.
Alongside investment and business trends, the report also provides technical insights into some of the latest AI applications and research achievements.